Results 121 to 130 of about 1,408,984 (372)

Multidimensional Recovery Among an Opioid Use Disorder Outpatient Treatment Population [PDF]

open access: yes, 2020
Background: Given the current opioid crisis, recovery from opioid use disorder (OUD) warrants attention. SAMHSA’s working definition of recovery highlights dimensions that support recovery including health, home, community, and purpose.
Beck, Lori   +2 more
core   +1 more source

Buprenorphine/naloxone maintenance therapy in patients with meperidine use disorder [PDF]

open access: yes, 2017
Meperidine hydrochloride is a synthetic opioid and a weak µ receptor agonist. Meperidine use disorder is mostly iatrogenic and is common in health care workers.
Erol, Atila   +3 more
core   +2 more sources

Ethnomedicinal uses, phytochemistry, pharmacological activities, and toxicology of the subfamily Gomphrenoideae (Amaranthaceae): A comprehensive review

open access: yesChemistry &Biodiversity, Accepted Article.
The subfamily Gomphrenoideae is composed of about 480 accepted species, many of which have been historically used as medicinal plants, reason why they have been studied in terms of chemical profile, biological activity, and safety. This review consolidates the advances in research on this subfamily over the past 47 years, emphasizing its promising ...
Dayanna Isabel Araque Gelves   +3 more
wiley   +1 more source

Editorial: Opioids in the time of the COVID-19 pandemic: from cellular mechanisms to public health policy

open access: yesFrontiers in Pharmacology, 2023
Scott John   +4 more
doaj   +1 more source

Towards Better Opioid Antagonists Using Deep Reinforcement Learning [PDF]

open access: yesarXiv, 2020
Naloxone, an opioid antagonist, has been widely used to save lives from opioid overdose, a leading cause for death in the opioid epidemic. However, naloxone has short brain retention ability, which limits its therapeutic efficacy. Developing better opioid antagonists is critical in combating the opioid epidemic.Instead of exhaustively searching in a ...
arxiv  

Substance Use Disorder Insurance Benefits: A Survey of State Benchmark Plans

open access: yes, 2019
Professor Tovino presents the results of a survey of state benchmark health plan coverage of substance use disorder treatments and services, including treatments and services for opioid use ...
Tovino, Stacey A.
core  

There Is Hope Out There [PDF]

open access: yes, 2022
This is a true story based on April’s journey through substance use disorder and recovery. April grew up in rural Utah with her large family and had a happy childhood.
Robinson, April
core   +1 more source

Speaking of Stigma: Piloting Language Training in Addiction Counseling Coursework

open access: yesCounselor Education and Supervision, EarlyView.
ABSTRACT This pilot study examined counselor‐in‐training (CIT) attitudes and awareness regarding stigma and stigmatizing language aimed at those with substance use disorders before and after an author‐developed educational intervention. Results indicated this intervention positively impacted CIT awareness and attitudes and their ability to identify and
Amy L. Grybush   +2 more
wiley   +1 more source

Further Structure‐Activity Relationship of G Protein‐Gated Inwardly Rectifying Potassium Channels 1/2 Activators: Synthesis and Biological Characterization of In Vitro Tool Compounds

open access: yesChemMedChem, EarlyView.
Work presented here details the design and characterize novel G protein‐gated inwardly rectifying potassium channels (GIRK)1/2 activators. A new 4,4‐difluorocyclohexylpyrazole have been identified that confers improved potency and selectivity for GIRK1/2 versus GIRK1/4.
Sumaiya Nahid   +8 more
wiley   +1 more source

The Individualized Treatment of Opioid Use Disorder [PDF]

open access: yesJournal of Managed Care & Specialty Pharmacy, 2019
No outside funding supported the writing of this commentary. Boyett is Chief Medical Officer and founder of the medical division of Pathway Healthcare, which provides treatment for opioid and other drug addictions.
openaire   +2 more sources

Home - About - Disclaimer - Privacy